The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...
The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include novel drugs that offer new treatment options, as well as first generics and ...
Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...
F O R T L A U D E R D A L E, Fla., May 1 -- If you had a choice between a costly prescription drug and its cheaper, generic version, which would you choose? Often, do you even have the choice?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results